Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice
We previously identified short synthetic shRNAs (sshRNAs) that target a conserved hepatitis C virus (HCV) sequence within the internal ribosome entry site (IRES) of HCV and potently inhibit HCV IRES-linked gene expression. To assess in vivo liver delivery and activity, the HCV-directed sshRNA, SG220...
Saved in:
Main Authors: | Anne Dallas (Author), Heini Ilves (Author), Joshua Shorenstein (Author), Adam Judge (Author), Ryan Spitler (Author), Christopher Contag (Author), Suet Ping Wong (Author), Richard P Harbottle (Author), Ian MacLachlan (Author), Brian H Johnston (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
by: Md. Emranul Karim, et al.
Published: (2018) -
Differential Regulation of Vascular Endothelial Growth Factors by Promoter-targeted shRNAs
by: Nihay Laham-Karam, et al.
Published: (2015) -
DROSHA Knockout Leads to Enhancement of Viral Titers for Vectors Encoding miRNA-Adapted shRNAs
by: Hee Ho Park, et al.
Published: (2018) -
Efficient Knockdown and Lack of Passenger Strand Activity by Dicer-Independent shRNAs Expressed from Pol II-Driven MicroRNA Scaffolds
by: Erik Kaadt, et al.
Published: (2019) -
Efficacy, accumulation, and transcriptional profile of anti-HIV shRNAs expressed from human U6, 7SK, and H1 promoters
by: Ryan P. Goguen, et al.
Published: (2021)